Xencor doses first subject in early-stage XmAB564 autoimmune disease study
April 28 2021 - 4:19PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Xencor (NASDAQ:XNCR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Xencor (NASDAQ:XNCR)
Historical Stock Chart
From Sep 2023 to Sep 2024